Testosterone stimulates adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3300-3308

  Zhu, Lijun ^a   Hou, Miao ^a   Sun, Bin ^a   Burén, Jonas ^b   Zhang, Li ^a   Yi, Jun ^a   Hernell, Olle ^b   Li, Xiaonan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HORMONE; HYDROCORTISONE; MESSENGER RNA; TESTOSTERONE;

ABDOMINAL SUBCUTANEOUS FAT; ABDOMINAL SURGERY; ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TEMPERATURE; OMENTUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SUBCUTANEOUS FAT; ADOLESCENT; DRUG EFFECT; GENETICS; INTRAABDOMINAL FAT; MALE; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADOLESCENT; CHILD; GENE EXPRESSION; HUMANS; HYDROCORTISONE; INTRA-ABDOMINAL FAT; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT, ABDOMINAL; TESTOSTERONE; UP-REGULATION;

EID: 77954926658     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2708     Document Type: Article

References (45)

1. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S 2002 Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802-810 (Pubitemid 34984653)
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374
3. Baker JL, Olsen LW, Sørensen TI 2007 Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 357:2329-2337
4. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L 2007 Adolescent overweight and future adult coronary heart disease. N Engl J Med 357:2371-2379
5. Bacha F, Saad R, Gungor N, Janosky J, Arslanian SA 2003 Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 88:2534-2540
6. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001Atransgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
7. Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, Courtney R, Rejto P, Carley W, Stewart PM 2007 Inhibition of 11β-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. J Clin Endocrinol Metab 92:857-864
8. Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87: 3330-3336
9. Muñoz R, Carvajal C, Escalona A, Boza C, Pérez G, Ibáñez L, Fardella C 2009 11β-Hydroxysteroid dehydrogenase type 1 is overexpressed in subcutaneous adipose tissue of morbidly obese patients. Obes Surg 19:764-770
10. Li X, Lindquist S, Chen R, Myrnas T, Angsten G, Olsson T, Hernell O 2007 Depot-specific messenger RNA expression of 11β-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults. Int J Obes (Lond) 31:820-828
11. Mericq V, Medina P, Bouwman C, Johnson MC, Godoy J, López T, Iñiguez G 2009 Expression and activity of 11β-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children. Horm Res 71:89-93
12. Simonyte K, Rask E, Naslund I, Angelhed JE, Lonn L, Olsson T, Mattsson C 2009 Obesity is accompanied by disturbances in peripheral glucocorticoid metabolism and changes in FA recycling. Obesity (Silver Spring) 17:1982-1987
13. Veilleux A, Rhéaume C, Daris M, Luu-The V, Tchernof A 2009 Omental adipose tissue 11β-HSD1 oxoreductase activity, body fat distribution and metabolic alterations in women. J Clin Endocrinol Metab 94:3550-3557
14. Blouin K, Boivin A, Tchernof A 2008 Androgens and body fat distribution. J Steroid Biochem Mol Biol 108:272-280
15. Anderson LA, McTernan PG, Harte AL, Barnett AH, Kumar S 2002 The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes Metab 4:209-213
16. Gupta V, Bhasin S, Guo W, Singh R, Miki R, Chauhan P, Choong K, Tchkonia T, Lebrasseur NK, Flanagan JN, Hamilton JA, Viereck JC, Narula NS, Kirkland JL, Jasuja R 2008 Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol Cell Endocrinol 296:32-40
17. Bujalska IJ, Quinkler M, Tomlinson JW, Montague CT, Smith DM, Stewart PM 2006 Expression profiling of 11β-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes. J Mol Endocrinol 37:327-340
18. Morita J, Hakuno F, Hizuka N, Takahashi S, Takano K 2009 Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11β-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates. Endocr J 56:561-570
19. Paulsen SK, Pedersen SB, Jørgensen JO, Fisker S, Christiansen JS, Flyvbjerg A, Richelsen B 2006 Growth hormone(GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab 91:1093-1098
20. Paulsen SK, Pedersen SB, Fisker S, Richelsen B 2007 11β-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 15:1954-1960
21. Dieudonné MN, Sammari A, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R 2006 Sex steroids and leptin regulate 11β-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: sex specificities. J Steroid Biochem Mol Biol 99:189-196
22. Wiegand S, Richardt A, Remer T, Wudy SA, Tomlinson JW, Hughes B, Grüters A, Stewart PM, Strasburger CJ, Quinkler M 2007 Reduced 11β-hydroxysteroid dehydrogenase type 1 activity in obese boys. Eur J Endocrinol 157:319-324
23. Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM 2005 Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11β-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 34:675-684
24. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM 2003 Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34:434-439
25. Hutley LJ, Newell FM, Joyner JM, Suchting SJ, Herington AC, Cameron DP, Prins JB 2003 Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest 33:574-581
26. Laplante M, Sell H, MacNaul KL, Richard D, Berger JP, Deshaies Y 2003 PPAR-γ activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion. Diabetes 52:291-299
27. Kurebayashi S, Sumitani S, Kasayama S, Jetten AM, Hirose T 2001 TNF-α inhibits 3T3-L1 adipocyte differentiation without down-regulating the expression of C/EBPβ and δ. Endocr J 48:249-253
28. Tomlinson JW, Moore J, Cooper MS, Bujalska I, Shahmanesh M, Burt C, Strain A, Hewison M, Stewart PM 2001 Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 142: 1982-1989
29. Marshall WA, Tanner JM 1970 Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
30. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH 2000 Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240-1243
31. Hausman GJ 1985 Anatomical and enzyme histochemical differentiation of adipose tissue. Int J Obes 9(Suppl 1):1-6
32. Casabiell X, Piñeiro V, Peino R, Lage M, Camiña J, Gallego R, Vallejo LG, Dieguez C, Casanueva FF 1998 Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 83: 2149-2155
33. Walker EA, Clark AM, Hewison M, Ride JP, Stewart PM 2001 Functional expression, characterization, and purification of the catalytic domain ofhuman11-β-hydroxysteroid dehydrogenase type 1. J Biol Chem 276:21343-21350
34. Burén J, Bergström SA, Loh E, Söderström I, Olsson T, Mattsson C 2007 Hippocampal 11β-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression has a diurnal variability that is lost in the obese Zucker rat. Endocrinology 148:2716-2722
35. Woodhouse LJ, Gupta N, Bhasin M, Singh AB, Ross R, Phillips J, Bhasin S 2004 Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab 89:718-726
36. Reinehr T, de Sousa G, Roth CL, Andler W 2005 Androgens before and after weight loss in obese children. J Clin Endocrinol Metab 90:5588-5595
37. Carranza-Lira S, Velasco Díaz G, Olivares A, Chán Verdugo R, Herrera J 2006 Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City. Int J Fertil Womens Med 51:83-88
38. Lee MJ, Fried SK, Mundt SS, Wang Y, Sullivan S, Stefanni A, Daugherty BL, Hermanowski-Vosatka A 2008 Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) 16:1178-1185
39. Yen PM, Liu Y, Palvimo JJ, Trifiro M, Whang J, Pinsky L, Jänne OA, Chin WW 1997 Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. Mol Endocrinol 11:162-171
40. Sai S, Esteves CL, Kelly V, Michailidou Z, Anderson K, Coll AP, Nakagawa Y, Ohzeki T, Seckl JR, Chapman KE 2008 Glucocorticoid regulation of the promoter of 11β-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-β. Mol Endocrinol 22:2049-2060
41. Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A 2004 Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett 571:129-133
42. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC, Stewart PM 2006 Hexose-6-phosphate dehydrogenase knock-out mice lack 11β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 281: 6546-6551
43. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866
44. Cawthorn WP, Heyd F, Hegyi K, Sethi JK 2007 Tumour necrosis factor-α inhibits adipogenesis via a β-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ 14:1361-1373
45. Pantoja C, Huff JT, Yamamoto KR 2008 Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol Biol Cell 19:4032-4041